164 related articles for article (PubMed ID: 33906182)
1. Machine learning-based personalized subthalamic biomarkers predict ON-OFF levodopa states in Parkinson patients.
Sand D; Rappel P; Marmor O; Bick AS; Arkadir D; Lu BL; Bergman H; Israel Z; Eitan R
J Neural Eng; 2021 May; 18(4):. PubMed ID: 33906182
[No Abstract] [Full Text] [Related]
2. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
[TBL] [Abstract][Full Text] [Related]
3. Balance between competing spectral states in subthalamic nucleus is linked to motor impairment in Parkinson's disease.
Khawaldeh S; Tinkhauser G; Torrecillos F; He S; Foltynie T; Limousin P; Zrinzo L; Oswal A; Quinn AJ; Vidaurre D; Tan H; Litvak V; Kühn A; Woolrich M; Brown P
Brain; 2022 Mar; 145(1):237-250. PubMed ID: 34264308
[TBL] [Abstract][Full Text] [Related]
4. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.
He S; Baig F; Merla A; Torrecillos F; Perera A; Wiest C; Debarros J; Benjaber M; Hart MG; Ricciardi L; Morgante F; Hasegawa H; Samuel M; Edwards M; Denison T; Pogosyan A; Ashkan K; Pereira E; Tan H
Brain; 2023 Dec; 146(12):5015-5030. PubMed ID: 37433037
[TBL] [Abstract][Full Text] [Related]
5. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
[TBL] [Abstract][Full Text] [Related]
6. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
[TBL] [Abstract][Full Text] [Related]
7. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
Evers J; Orłowski J; Jahns H; Lowery MM
Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
[TBL] [Abstract][Full Text] [Related]
8. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
[TBL] [Abstract][Full Text] [Related]
10. An external portable device for adaptive deep brain stimulation (aDBS) clinical research in advanced Parkinson's Disease.
Arlotti M; Rossi L; Rosa M; Marceglia S; Priori A
Med Eng Phys; 2016 May; 38(5):498-505. PubMed ID: 27029510
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical Modulation of STN β-Band Activity with Medication Compared to Deep Brain Stimulation.
Hill ME; Johnson LA; Wang J; Escobar Sanabria D; Patriat R; Cooper SE; Park MC; Harel N; Vitek JL; Aman JE
Mov Disord; 2024 Jan; 39(1):192-197. PubMed ID: 37888906
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
14. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
19. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
20. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
